Polfarmex to increase production thanks to a new packaging line
Polfarmex has invested in a new packaging line, which has appeared at its production plant in Kutno. Thanks to the…
biosimilar drugs
Teva to commercialise Polpharma’s biosimilar drug
Polpharma Biologics Group’s joint venture has entered into an agreement with Teva to commercialise a biosimilar drug to Ranibizumab. The…
Bioton: Jeremy Launders as President of the Management Board
Robert Neymann has resigned from the position of President of the Management Board at Bioton. Although his term of office…
Romaniszyn new General Manager in Stada
Paulina Romaniszyn was appointed as Country Head and General Manager in the Polish branch of Stada. The new Head will…
PMR report: The number of companies on the biological drugs market is growing
According to forecasts presented in the PMR report “Biological and biosimilar drugs market in Poland 2019. Market analysis and development…
Dirk Kreder is the new president of Mabion
Dirk Kreder was appointed president of the Polish biotechnology company Mabion. New president of Mabion Dirk Kreder has extensive experience…
PMR report: Biological medicines market in Poland strongly consolidated
Due to the relatively small number of drugs and the high barriers to entry, the market for biological medicines is…
PMR: Biological medicines market in Poland 2019
PMR presents a set of infographics from the report: Biological and biosimilar medicines market in Poland 2019. Market analysis and development…
PMR report: Impressive growth of biological medicines
According to the forecasts presented in PMR’s latest report “Biological and biosimilar medicines market in Poland 2019. Market analysis and…
PMR report: Reimbursement is crucial for biological medicines
Introduction of biosimilar drugs to reimbursement in Poland takes almost the longest time in Europe. Nevertheless, obtaining reimbursement is a…
